Article Text
Statistics from Altmetric.com
Obesity is recognised as a risk factor for triggering rheumatoid arthritis (RA), and it can worsen joint deformities1 and diminish the quality of life in patients with RA.2 The reduction of body weight in obese individuals is believed to alleviate RA symptoms.3 Body mass index (BMI) serves as the primary standard for evaluating obesity.4 An increase in BMI by 1 SD notably elevates the incidence rate of RA, suggesting a causal link between higher BMI and an increased risk of developing RA.5
The association between BMI and obesity is straightforward, as a higher BMI typically indicates a greater risk of obesity.4 Obesity is clinically defined as having a BMI of 30 kg/m2 or greater.4 Here, we established collagen-induced arthritis (CIA) models in mice using both regular and high-fat diets (HFDs) to see if HFD can induce severe RA symptoms in mice. CIA mice develop arthritis symptoms, including joint swelling, redness and stiffness, mirroring the clinical features of human RA.6 Therefore, the CIA model has become the prevailing animal model for RA research.
Our observations indicated that mice in the HFD sham group exhibited significantly higher body weights compared with regular diet group, in line with previous reports.7 However, the HFD CIA model group did not show a significant difference in body weight compared with mice on a regular diet (figure 1A). Interestingly, although the HFD did not induce higher body weight in the CIA model, arthritis incidence was notably higher in HFD-fed mice starting from day 30 when compared with those on regular diets (figure 1B). Furthermore, the HFD sham group displayed significantly higher levels of cholesterol (CHO) and high-density lipoprotein (HDL) compared with the regular diet sham group, whereas the HFD CIA group exhibited similar serum levels of CHO, HDL, low-density lipoprotein and triglycerides compared with the regular diet CIA group (figure 1C).
To gain insights into the mechanisms behind the exacerbation of arthritis by HFD, we collected synovial tissue and performed RNA sequencing. Our RNA-Seq analysis revealed that 217 genes in the HFD CIA model were significantly upregulated, while 354 genes were significantly downregulated compared with the regular diet CIA model (figure 1D). Gene Ontology analysis demonstrated the activation of pathways related to inflammatory responses in the HFD CIA model (figure 1E), indicating that HFD leads to inflammation in synovial tissue. Our tissue immunohistochemistry experiments revealed higher expression of the inflammatory representative factors IL-1b and TNF-α in HFD-CIA compared with CIA in the regular diet (online supplemental figure S1). Interestingly, CIA model mice on HFD did not exhibit more severe subchondral erosion (online supplemental figure S2) or cartilage damage (online supplemental figure S3) when compared with CIA model mice on a regular diet.
Supplemental material
In summary, HFD did not lead to an increase in body weight or greater subchondral erosion and cartilage damage in the CIA model. However, it significantly exacerbated the rheumatic index. Given that HFD has been reported to induce chronic inflammation,8 which aligns with the activation of inflammatory pathways found in our sequencing analysis. We conclude here that a single BMI measurement may not be sufficient as an indicator of RA disease risk. It is advisable to consider the adoption of a HFD and its fat content when assessing the risk of RA.
Data availability statement
The RNA-Seq data were deposited in GEO (GSE260460).
Ethics statements
Patient consent for publication
Supplementary materials
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Footnotes
JL, KY and YS contributed equally.
Contributors Conceptualisation, YW and QX; Data curation, QX, YS and JL; Funding acquisition, YW and KY; Investigation, JL, YS, KY and LL; Methodology, QX, YS and JL and LL; Project administration, QX; Supervision, YW; Validation, JL and YS; Visualisation, YW; Writing—original draft, QX. All authors have read and agreed to the published version of the manuscript.
Funding This work was supported by the National Natural Science Foundation of China (82174033 to YW), and the Project for High Efficiency and Developed Hospital at Foshan City (202000189, 202200089 to KY).
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.